Europe - Euronext Brussels - EBR:CAND - BE0974298300 - Common Stock
The current stock price of CAND.BR is 2.3 EUR. In the past month the price increased by 39.39%. In the past year, price decreased by -47.73%.
ChartMill assigns a technical rating of 2 / 10 to CAND.BR. When comparing the yearly performance of all stocks, CAND.BR is a bad performer in the overall market: 96.9% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to CAND.BR. The financial health of CAND.BR is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months CAND.BR reported a non-GAAP Earnings per Share(EPS) of -0.7. The EPS decreased by -449.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.85% | ||
| ROE | -32.9% | ||
| Debt/Equity | 2.17 |
Candela Invest SA engages in the provision of investment services. The company is headquartered in Brussels, Bruxelles-Capitale. The company went IPO on 2009-12-30. The firm invests in both listed and non-listed entities operating in various sectors, such as healthcare, biotechnology, information technology (IT), software, electronics, communications, distribution, financial, transport, industry, and real estate, among others. The company focuses on long-term holdings, although it may be also engaged in medium-term investments and also in companies that are considering a stock market entry. The company absorbed Arseus 2012 SPRL.
CANDELA INVEST
Lenniksebaan 451 / 32
Brussels BRUXELLES-CAPITALE BE
Employees: 26
Phone: 323211880920
Candela Invest SA engages in the provision of investment services. The company is headquartered in Brussels, Bruxelles-Capitale. The company went IPO on 2009-12-30. The firm invests in both listed and non-listed entities operating in various sectors, such as healthcare, biotechnology, information technology (IT), software, electronics, communications, distribution, financial, transport, industry, and real estate, among others. The company focuses on long-term holdings, although it may be also engaged in medium-term investments and also in companies that are considering a stock market entry. The company absorbed Arseus 2012 SPRL.
The current stock price of CAND.BR is 2.3 EUR. The price increased by 35.29% in the last trading session.
CAND.BR does not pay a dividend.
CAND.BR has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
CANDELA INVEST (CAND.BR) has a market capitalization of 2.48M EUR. This makes CAND.BR a Nano Cap stock.